HDFC Life Insurance reports FY26 financial results with 6% PAT growth and 8% APE rise
HDFC Life Insurance Company · Insurance
Key highlights
- FY26 Profit After Tax (PAT) increased to ₹1,910 crore, a 6% year-on-year growth
- New Business Annualized Premium Equivalent (APE) rose 8% to ₹16,641 crore; Value of New Business ₹4,034 crore at 24.2% margin
- Solvency ratio stood at 177% as of March 2026; proposed preferential issue of up to ₹1,000 crore approved to augment solvency
Why it's rated notable: amount is ₹500 crore or more
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from HDFC Life Insurance Company
- Fundraise / allotmentNotableHDFC Life Insurance files Q2 FY27 financial results and approves NCD issuance
- Fundraise / allotmentNotableHDFC Life allots 1.45 crore shares to HDFC Bank on preferential basis
- Fundraise / allotmentNotableHDFC Life Insurance Company passes special resolution for preferential share issue
- Fundraise / allotmentNotableHDFC Life announces audited FY26 results, dividend, re-appointment, and share issue
- Fundraise / allotmentNotableHDFC Life to consider financial results and proposed preferential share issue on April 16, 2026
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
Potential multibaggers in Insurance
on management's own guidance
- Max FinancialModerate growth2
- Niva Bupa HealthGood growth1
- 3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.